Novus Life Sciences Private Limited - Charges

Every charge - open or closed - that lenders have registered against Novus Life Sciences Private Limited, with the most recent activity at t…

2007-10-09 Mumbi, Maharashtra Active Unlisted Active Compliant
Share
NL Novus Life Sciences Private Limited
Open charges
4
7.26 cr
Closed charges
0
0.00
Total
4
7.26 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Hdfc Bank Limited 2 5.30 cr
2 Indian Bank 1 1.30 cr
3 Others 1 66.00 Lakh
All charges (4) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
101029051 Hdfc Bank Limited 28 Nov 2024 - - 2.50 cr Open
100888027 Hdfc Bank Limited 01 Mar 2024 - - 2.80 cr Open
100790372 Others 10 Aug 2023 - - 66.00 Lakh Open
10470569 Indian Bank 11 Sep 2013 26 May 2022 - 1.30 cr Open
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Novus Life Sciences Private Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Novus Life Sciences Private Limited (CIN: U24232MH2007PTC174821). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Novus Life Sciences Private Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.